Antibodies to the high-density lipoprotein receptor SR-B1 potently inhibit hepatitis C virus replication in vivo: New avenues for preventing reinfection of the liver following transplantation

Hepatology. 2014 Nov;60(5):1463-5. doi: 10.1002/hep.27276. Epub 2014 Sep 18.

Author

Heidi E Drummer¹

Affiliation

¹ Viral Fusion Laboratory, Centre for Biomedical Research, Burnet Institute, Melbourne, Australia; Department of Microbiology, Monash University, Clayton, Australia; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Parkville, Australia.

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Animals
Antibodies, Monoclonal / therapeutic use*
Hepatitis C / drug therapy*
Humans
Scavenger Receptors, Class B / immunology*

Substances

Antibodies, Monoclonal
SCARB1 protein, human
Scavenger Receptors, Class B